Table 2.
Monthly dispensings of angiotensin receptor blockers in DID from January 2017 to December 2019.
| DID | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Month | Valsartan | Candesartan | Losartan | Telmisartan | Irbesartan | Olmesartan | Eprosartan | Azilsartan | All ARBs |
| Jan 2017 | 36.9 | 50.5 | 7.7 | 6.3 | 4.8 | 0.4 | 0.4 | 0.02 | 106.9 |
| Feb 2017 | 36.7 | 50.4 | 7.7 | 6.3 | 4.7 | 0.4 | 0.4 | 0.01 | 106.6 |
| Mar 2017 | 38.6 | 53.2 | 7.9 | 6.6 | 4.9 | 0.5 | 0.4 | 0.02 | 112.0 |
| Apr 2017 | 37.2 | 51.3 | 7.6 | 6.4 | 4.8 | 0.5 | 0.4 | 0.02 | 108.2 |
| May 2017 | 39.1 | 54.1 | 7.9 | 6.6 | 4.9 | 0.6 | 0.4 | 0.02 | 113.7 |
| June 2017 | 38.3 | 52.6 | 7.7 | 6.4 | 4.8 | 0.6 | 0.3 | 0.02 | 110.8 |
| July 2017 | 38.5 | 53.2 | 7.7 | 6.4 | 4.8 | 0.7 | 0.3 | 0.01 | 111.6 |
| Aug 2017 | 37.0 | 51.0 | 7.4 | 6.2 | 4.5 | 0.7 | 0.3 | 0.01 | 107.1 |
| Sep 2017 | 37.5 | 51.7 | 7.4 | 6.2 | 4.5 | 0.7 | 0.3 | 0.01 | 108.2 |
| Oct 2017 | 38.1 | 52.9 | 7.5 | 6.3 | 4.6 | 0.8 | 0.3 | 0.01 | 110.4 |
| Nov 2017 | 43.4 | 60.1 | 8.4 | 7.0 | 5.1 | 0.9 | 0.3 | 0.02 | 125.3 |
| Dec 2017 | 37.9 | 52.8 | 7.4 | 6.2 | 4.4 | 0.8 | 0.3 | 0.01 | 109.7 |
| Jan 2018 | 40.8 | 56.6 | 7.9 | 6.4 | 4.6 | 0.9 | 0.3 | 0.01 | 117.5 |
| Feb 2018 | 39.5 | 55.4 | 7.7 | 6.2 | 4.5 | 1.0 | 0.3 | 0.02 | 114.5 |
| Mar 2018 | 39.3 | 55.4 | 7.6 | 6.2 | 4.5 | 1.0 | 0.3 | 0.01 | 114.1 |
| Apr 2018 | 42.0 | 58.9 | 8.1 | 6.5 | 4.7 | 1.1 | 0.3 | 0.01 | 121.5 |
| May 2018 | 40.1 | 56.2 | 7.7 | 6.1 | 4.4 | 1.0 | 0.3 | 0.01 | 115.8 |
| June 2018 | 41.2 | 57.9 | 7.9 | 6.3 | 4.5 | 1.1 | 0.3 | 0.01 | 119.1 |
| July 2018 | 41.8 | 69.6 | 8.5 | 6.8 | 4.8 | 1.4 | 0.3 | 0.01 | 133.3 |
| Aug 2018 | 28.9 | 67.5 | 8.0 | 6.3 | 4.4 | 1.4 | 0.3 | 0.01 | 116.7 |
| Sep 2018 | 27.4 | 62.0 | 7.5 | 5.9 | 4.1 | 1.3 | 0.3 | 0.01 | 108.4 |
| Oct 2018 | 33.2 | 73.0 | 8.5 | 6.8 | 4.8 | 1.5 | 0.3 | 0.01 | 127.9 |
| Nov 2018 | 30.8 | 76.7 | 8.8 | 7.0 | 4.8 | 1.6 | 0.3 | 0.01 | 130.0 |
| Dec 2018 | 25.5 | 68.7 | 7.7 | 6.1 | 4.2 | 1.5 | 0.2 | 0.01 | 113.8 |
| Jan 2019 | 32.8 | 79.4 | 8.6 | 6.9 | 4.8 | 1.7 | 0.3 | 0.01 | 134.4 |
| Feb 2019 | 26.9 | 79.7 | 8.3 | 6.9 | 4.6 | 1.7 | 0.3 | 0.01 | 128.3 |
| Mar 2019 | 22.1 | 74.3 | 7.6 | 6.3 | 4.2 | 1.6 | 0.2 | 0.01 | 116.5 |
| Apr 2019 | 19.6 | 90.5 | 8.8 | 7.4 | 4.9 | 1.9 | 0.3 | 0.01 | 133.3 |
| May 2019 | 10.0 | 101.6 | 8.9 | 7.6 | 4.9 | 2.1 | 0.2 | 0.01 | 135.3 |
| June 2019 | 13.0 | 90.0 | 8.0 | 6.9 | 4.5 | 1.8 | 0.2 | 0.01 | 124.4 |
| July 2019 | 17.6 | 99.2 | 9.1 | 7.7 | 5.0 | 1.9 | 0.3 | 0.01 | 140.8 |
| Aug 2019 | 13.9 | 90.0 | 7.9 | 6.7 | 4.4 | 1.9 | 0.2 | 0.01 | 125.0 |
| Sep 2019 | 13.9 | 91.3 | 7.9 | 6.8 | 4.4 | 1.9 | 0.2 | 0.01 | 126.4 |
| Oct 2019 | 17.2 | 101.0 | 9.1 | 7.6 | 4.6 | 2.1 | 0.2 | 0.01 | 141.8 |
| Nov 2019 | 18.1 | 104.4 | 9.0 | 7.8 | 2.9 | 2.2 | 0.2 | 0.01 | 144.6 |
| Dec 2019 | 15.5 | 93.9 | 8.0 | 7.0 | 3.6 | 2.0 | 0.2 | 0.01 | 130.1 |
ARB angiotensin receptor blocker, DID defined daily doses per 1000 statutory health insurance-insured persons per day.